Last Updated:
COVID-19 Vaccine Jabs Won't Increase Immunity In Organ Transplant Patients: Study
A new study eveals that people who have had organ transplants remain vulnerable to the deadly Covid-19 infections even after the second dose of the vaccine.
IMAGE: PTI
A new study published in the Journal of the American Medical Association (JAMA) reveals that people who have had organ transplants remain vulnerable to the deadly COVID-19 infections even after the second dose of the vaccine. Led by the researchers at Johns Hopkins University in the United States, the study concluded that in contrast to immunocompetent participants in vaccine trials, a proportion as low as 17 per cent of solid organ transplant recipients mounted a positive antibody response to the first dose of SARS-CoV-2 messenger RNA (mRNA) vaccines. However, for those receiving anti–metabolite maintenance immunosuppression were less likely to respond. As a part of the study, the researchers assessed antibody response after the second dose. The Johns Hopkins Medicine research team includes William Werbel, Robin Avery, Aaron Tobian, Allan Massie and Jacqueline Garonzik-Wang.

Related Keywords

United States , American , Brian Boyarsky , Jacqueline Garonzik Wang , Robin Avery , Allan Massie , William Werbel , Aaron Tobian , Johns Hopkins University , Johns Hopkins University School Of Medicine , Journal Of The American Medical Association , American Medical Association , Johns Hopkins Medicine , Johns Hopkins University School , ஒன்றுபட்டது மாநிலங்களில் , அமெரிக்கன் , ராபின் காவேரி , ஆலன் மாஸி , ஜான்ஸ் ஹாப்கின்ஸ் பல்கலைக்கழகம் , ஜான்ஸ் ஹாப்கின்ஸ் பல்கலைக்கழகம் பள்ளி ஆஃப் மருந்து , இதழ் ஆஃப் தி அமெரிக்கன் மருத்துவ சங்கம் , அமெரிக்கன் மருத்துவ சங்கம் , ஜான்ஸ் ஹாப்கின்ஸ் மருந்து , ஜான்ஸ் ஹாப்கின்ஸ் பல்கலைக்கழகம் பள்ளி ,